Friedreich's Ataxia: Hope on the Horizon | Limerick News

Friedreich’s Ataxia patients in Ireland are fighting for life-changing access to Skyclarys, a drug proven to slow the disease and improve neurological function — despite its €288,000 annual cost and HSE’s initial refusal to fund it. Families, advocates, and doctors are rallying, with emotional stories from survivors like Emma O’Shea and Emily Felix, who describe losing control of their lives as the disease progresses. With a final HSE decision looming on August 25th and a public demonstration planned for Sunday in Dublin, hundreds of Irish patients are pleading for the chance to live fuller, healthier lives — and see their children grow up. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e97510ccbf64ae9a